Gregory J. Divis, Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 19,598 shares at $9.98 ($196K) on 2024-12-06, disclosed to the SEC on 2024-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.98 | 9,598 | $96K | 49.0% |
| 2 | $9.98 | 9,598 | $96K | 49.0% |
| 3 | $9.82 | 402 | $4K | 2.0% |
| Total | $9.98 avg | 19,598 | $196K | 100% |
| Filing → |
| AVDL | BUY | 2020-08-13 | $101K | — | Filing → |